Hepatitis C news from FiercePharma
NewsDocs back Viread for hepatitis B
Analysts are chatting up Gilead Science's HIV drug Viread as a treatment for hepatitis B. Currently under FDA review for that indication, Viread already has the backing of four out of five doctors,... Read more...
| Press ReleasesPRESS RELEASE: Roche signs licensing and settlement agreements for Hepatitis C immunodiagnostics Roche signs licensing and settlement agreements for Hepatitis C immunodiagnostics Roche announced today licensing and settlement agreements with Ortho-Clinical Diagnostics, Inc. and Novartis Read more >> PRESS RELEASE: OctoPlus presents positive Phase IIa study results for Locteron in hepatitis C at AASLD conference OctoPlus presents positive Phase IIa study results for Locteron in hepatitis C at AASLD conference OctoPlus, the drug delivery and development company, announces that full and complete results from Read more >> |
Get more Hepatitis C coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
